OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
Chilam Chan, Marta Lustig, Niklas Baumann, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11

Showing 11 citing articles:

Therapeutic Monoclonal Antibodies against Cancer: Present and Future
Marisa Delgado, José A. García‐Sanz
Cells (2023) Vol. 12, Iss. 24, pp. 2837-2837
Open Access | Times Cited: 31

Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
Marta Lustig, Chilam Chan, J.H. Marco Jansen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Immune inhibitory receptor agonist therapeutics
Rustin R. Lovewell, Solomon Langermann, Dallas B. Flies
Frontiers in Immunology (2025) Vol. 16
Open Access

Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade
Chilam Chan, Marjolein C. Stip, Maaike Nederend, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 5, pp. e008478-e008478
Open Access | Times Cited: 3

Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody
Patricia A. Olofsen, Marjolein C. Stip, J.H. Marco Jansen, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3406-3406
Open Access | Times Cited: 11

Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains
Marjolein C. Stip, J.H. Marco Jansen, Maaike Nederend, et al.
Cancer Immunology Immunotherapy (2023) Vol. 72, Iss. 9, pp. 3063-3077
Open Access | Times Cited: 5

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
Chilam Chan, Marta Lustig, J.H. Marco Jansen, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3405-3405
Open Access | Times Cited: 5

Role of glutaminyl-peptide cyclo-transferase-like protein (QPCTL) in cancer: From molecular mechanisms to immunotherapy
Enwa Felix Oghenemaro, Subasini Uthirapathy, Deepak Nathiya, et al.
Gene (2024), pp. 149153-149153
Closed Access | Times Cited: 1

Role of the bone marrow microenvironment in multiple myeloma treatment using CAR-T therapy
Hao Yao, Lei Cheng, Dan Chen, et al.
Expert Review of Anticancer Therapy (2023) Vol. 23, Iss. 8, pp. 807-815
Closed Access | Times Cited: 3

SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity
Panagiota Bouti, Colin Blans, Bart Klein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17141-17141
Open Access | Times Cited: 2

The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy
Chilam Chan, Núria Casalé Cabanes, J.H. Marco Jansen, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 12
Open Access

Page 1

Scroll to top